A Study for Treatment of Superficial Bladder Cancer Using OGX-427

NCT00959868 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

OTHER_GOV

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: OGX-427

Sponsor

Vancouver Coastal Health

Collaborators

[object Object]
[object Object]